玄武雲(02392.HK)向54名核心員工授予498.5萬股獎勵股份
格隆匯1月6日丨玄武雲(02392.HK)公佈,2023年1月6日,公司議決根據限制性股份獎勵計劃授出獎勵股份。2023年1月6日,54名選定參與者獲授498.5萬股獎勵股份,選定參與者為長期為公司服務的部分核心員工,並非公司關連人士。
授予的獎勵股份通常於授出日期起計約三年內歸屬予選定參與者。按獎勵股份授出日期的收市價每股3.00港元計算,合共498.5萬股獎勵股份的市值為1495.5萬港元。
授予限制性股份獎勵旨在(1)為選定參與者提供獲得公司所有權權益的機會;(2)鼓勵及挽留該等人士為集團效力;(3)為彼等提供達成績效目標的額外獎勵;(4)為集團進一步發展吸納合適人才;及(5)激勵選定參與者為選定參與者及公司的利益最大化公司價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.